{"title":"Cardiac","description":"\u003cp\u003e\u003cstrong data-start=\"0\" data-end=\"85\" data-is-only-node=\"\"\u003eCardiac inflammation testing using the CLIA (Chemiluminescent Immunoassay) method\u003c\/strong\u003e is used to detect markers related to heart damage or heart-related inflammation in blood samples. In this method, a patient’s blood serum is mixed with reagents containing specific antibodies that bind to cardiac biomarkers such as \u003cstrong data-start=\"318\" data-end=\"330\"\u003eTroponin\u003c\/strong\u003e, \u003cstrong data-start=\"332\" data-end=\"341\"\u003eCK-MB\u003c\/strong\u003e, or \u003cstrong data-start=\"346\" data-end=\"374\"\u003eC-reactive protein (CRP)\u003c\/strong\u003e. If these markers are present, an antigen–antibody reaction occurs, and a chemiluminescent substance produces light during the reaction. The laboratory analyzer measures the intensity of this light, and the amount of light produced is directly proportional to the concentration of the cardiac marker in the sample. This method is highly sensitive and rapid, so it is commonly used to help diagnose heart conditions such as \u003cspan class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"\u003e\u003cspan class=\"whitespace-normal\"\u003eMyocardial Infarction\u003c\/span\u003e\u003c\/span\u003e and to monitor cardiac inflammation or injury.\u003c\/p\u003e","products":[{"product_id":"d-dimer","title":"D-Dimer","description":"\u003cp\u003e\u003cspan\u003eThis assay is intended for the quantitative determination of D-Dimer in human plasma and whole blood. D-dimer is a degradation product of cross linked fibrin. The d-dimer concentration is a measure of the fibrinolytic activity of plasmin in the vascular system. Elevated concentrations of d-dimer indicate increased coagulatory and fibrinolytic activity. With a normal d-dimer value, acute deep vein thrombosis and pulmonary embolisms may be ruled out with very high reliability.\u003c\/span\u003e\u003c\/p\u003e","brand":"Enlight","offers":[{"title":"12 TESTS","offer_id":52728647713067,"sku":null,"price":5670.0,"currency_code":"INR","in_stock":true},{"title":"24 TESTS","offer_id":52728647745835,"sku":null,"price":10404.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0973\/1827\/3323\/files\/D-DIMER-01.jpg?v=1772697178"},{"product_id":"b-type-natriuretic-peptide","title":"B type Natriuretic Peptide","description":"\u003cp\u003e\u003cspan\u003eThis assay is intended for the quantitative determination of B-type natriuretic peptide in human plasma. Congestive heart failure (CHF) occurs when the heart cannot deliver a sufficient amount of blood to the body. This condition can occur at any age but is most prevalent in an aged population. Symptoms of CHF include shortness of breath, fluid retention, and respiratory distress. These symptoms are often vague and nonspecific for detecting early stages of CHF. B-type natriuretic peptide (BNP) is a member of a class of hormones that regulate blood pressure. The heart is the main source of circulating BNP in humans. The molecule is released into the blood in response to increased heart pressure. Various studies have demonstrated that increased levels of circulating BNP are found in early stages of CHF. The level of BNP in the blood continues to increase as the CHF disease advances.\u003c\/span\u003e\u003c\/p\u003e","brand":"Enlight","offers":[{"title":"12 TESTS","offer_id":52728639619371,"sku":null,"price":6804.0,"currency_code":"INR","in_stock":true},{"title":"24 TESTS","offer_id":52728639652139,"sku":null,"price":12276.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0973\/1827\/3323\/files\/BNP-01.jpg?v=1772697386"},{"product_id":"n-terminal-pro-b-type-natriuretic-peptide","title":"N-terminal pro-B type Natriuretic Peptide","description":"\u003cp\u003e\u003cspan\u003eThis assay is intended for the quantitative determination of N-terminal pro B-type natriuretic peptide in human serum and plasma. Heart failure is a clinical syndrome characterized by systemic perfusion inadequate to meet the body's metabolic demands as a result of a structural and\/or functional cardiac abnormality, resulting in a reduced cardiac output and\/or elevated intracardiac pressures at rest or during stress. Left ventricular dysfunction can be one of the functional precursors of heart failure. Several studies have demonstrated the significant role of natriuretic peptide testing, including NT-proBNP, in heart failure management from diagnosis to monitoring, leading to the recommendation to use them in clinical practice by major international guidelines with often highest level of evidence and recommendation.\u003c\/span\u003e\u003c\/p\u003e","brand":"Enlight","offers":[{"title":"12 TESTS","offer_id":52728634376491,"sku":null,"price":6804.0,"currency_code":"INR","in_stock":false},{"title":"24 TESTS","offer_id":52728634409259,"sku":null,"price":12276.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0973\/1827\/3323\/files\/NT-proBNP-01_e1941092-1b04-463d-804d-67fe97cb1cd4.jpg?v=1772698292"},{"product_id":"creatine-kinase-mb","title":"Creatine kinase-MB","description":"\u003cp\u003e\u003cspan\u003eThis assay is intended for the quantitative determination of CK-MB in human serum and plasma. Creatine kinase (CK) is a dimeric enzyme which occurs in 4 different forms: a mitochondrial isoenzyme and the cytosolic isoenzymes CK-MM (muscle type), CK-BB (brain type) and CK MB (muscle-brain type). CK-MB is an important biomarker of acute myocardial infarction and other causes of myocardial injury, such as heart failure and myocarditis. CK-MB is detectable in the blood about 3-8 hours after the onset of cardiac symptoms and can remain detectable over a lengthy period of time, depending on the course of the condition. CK-MB may also appear in other clinical conditions, e.g. in rhabdomyolysis and stroke. Within the scope of laboratory diagnostics, the determination of total CK, troponin T and\/or myoglobin can contribute to the differentiation of these clinical pictures. Because of their higher sensitivity and specificity, cardiac troponins, measured by high-sensitivity assays, are the preferred biomarkers to define myocardial infarction, and if a troponin assay is not available, the best alternative is CK-MB measured by a mass assay.\u003c\/span\u003e\u003c\/p\u003e","brand":"Enlight","offers":[{"title":"24 TESTS","offer_id":52728618254635,"sku":null,"price":7956.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0973\/1827\/3323\/files\/CK-MB-01.jpg?v=1772698493"},{"product_id":"myoglobin","title":"Myoglobin","description":"\u003cp\u003e\u003cspan\u003eThis assay is used for the quantitative determination of myoglobin (MYO) in human serum and plasma. Myoglobin is a small cytoplasmic protein (17.8 kDa) found in cardiac and skeletal muscle, where it facilitates oxygen transport and storage. Following myocardial injury, myoglobin is rapidly released into the bloodstream, making it an early biomarker for acute myocardial infarction (AMI), with levels rising within 2 hours of symptom onset and peaking quickly during reperfusion. It is also useful in detecting early reinfarction and successful reperfusion after lysis therapy. However, elevated myoglobin can also result from skeletal muscle damage or impaired kidney function. While cardiac troponins are the preferred markers for myocardial injury due to their higher specificity and sensitivity, myoglobin may still be used alongside other biomarkers when high-sensitivity troponin assays are unavailable.\u003c\/span\u003e\u003c\/p\u003e","brand":"Enlight","offers":[{"title":"24 TESTS","offer_id":52728612389163,"sku":null,"price":9468.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0973\/1827\/3323\/files\/MYO_-_01.jpg?v=1772698898"},{"product_id":"high-sensitive-cardiac-troponin-t-hs-ctnt","title":"High sensitive Cardiac Troponin T (hs-cTnT)","description":"\u003cp\u003e\u003cspan\u003eThis assay is used for the quantitative determination of cardiac troponin T (cTnT) in human serum and plasma. cTnT, encoded by the TNN2 gene, is a structural protein essential for muscle contraction in the heart, with isoform 6 (TnT3) being predominant in adult myocardial tissue. Most cTnT is bound within cardiac muscle fibers, while a small portion exists freely in the cytoplasm. During myocardial injury, such as necrosis or increased membrane permeability, cTnT is released into the bloodstream—initially in a free form, followed by the slower release of the bound form. It appears early and can remain detectable for up to two weeks, making it a highly specific and sensitive marker for myocardial damage. High-sensitivity cTnT assays enable earlier detection and confirmation or exclusion of acute myocardial infarction (AMI), and they are recommended for diagnosing, managing, and risk-stratifying acute coronary syndrome (ACS). Common detection methods include immunofluorescence and chemiluminescence.\u003c\/span\u003e\u003c\/p\u003e","brand":"Enlight","offers":[{"title":"12 TESTS","offer_id":52728602591531,"sku":null,"price":5292.0,"currency_code":"INR","in_stock":false},{"title":"24 TESTS","offer_id":52728602624299,"sku":null,"price":9468.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0973\/1827\/3323\/files\/hs-cTnT-01.jpg?v=1772699085"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0973\/1827\/3323\/collections\/cardic.jpg?v=1772686288","url":"https:\/\/shop.encorebiomedicals.com\/collections\/cardiac.oembed","provider":"Encore Biomedicals ","version":"1.0","type":"link"}